Lost Ground: Cancer Screening in the COVID-19 Era
A pandemic-related drop in cancer diagnoses could spell long-term trouble for patients and providers.
A pandemic-related drop in cancer diagnoses could spell long-term trouble for patients and providers.
From - Diagnostic Testing & Emerging Technologies
Clinicians are increasingly using genomic cancer testing in community health care settings, although there are…
From - Diagnostic Testing & Emerging Technologies
The U.S. Centers for Disease Control and Prevention (CDC) announced a…
From - Diagnostic Testing & Emerging Technologies
The hope of developing a single blood test capable of detecting multiple types of early-stage cancer is…
From - Diagnostic Testing & Emerging Technologies
To control the spread of HIV in the United States, HIV infection must be diagnosed early and persons with HIV infection must be…
From - Diagnostic Testing & Emerging Technologies
The European Centre for Disease Control and Prevention (ECDC) estimates that there are 9 million cases of health care-associated infections…